Clobazam, a compound primarily employed for the treatment of certain epileptic seizures, and increasingly, for anxiety situations, represents an crucial therapeutic possibility across the EU. This article aims to provide vital information specifically adapted for EU patients, addressing everything from its process of action and recommended dosages

While ketamine has shown potential as a treatment for severe depression, its availability varies significantly across Australia. Right now, ketamine therapy is primarily offered in specialized clinics and hospitals, often with a focus on patients who haven't responded to traditional antidepressant medications. The regulatory landscape continues com